RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 6,270.00
-80.00 (-1.26%)
At close: Mar 31, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 54.34 billion as of April 1, 2026. Its market cap has increased by 21.28% in one year.
Market Cap
54.34B
Enterprise Value
58.84B
Revenue
134.21B
Ranking
n/a
PE Ratio
11.11
Stock Price
6,270.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 54.34B, a decrease of -62.05%. That is a compound annual growth rate of -24.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 54.34B | -15.27% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GL Pharm Tech | 80.65B |
| Cosmax Nbt | 77.70B |
| Optipharm.CO.,LTD | 73.50B |
| Sinil Pharmaceutical | 67.35B |
| Kyung Nam Pharm | 61.97B |
| Jin Yang Pharmaceutical | 56.55B |
| Korea Arlico Pharm | 50.89B |
| Eagle Veterinary Technology Co.,Ltd | 48.04B |